A new model for curing disease
We are an alliance of patients, caregivers, doctors, researchers, drug developers and entrepreneurs pioneering a new approach to curing diseases through innovative outcome-based financing.
We educate, motivate and collaborate with impact investors and payers to discover life-altering therapies and bring them to patients.
Our Target is Chronic Pancreatitis
The first disease we are attacking is pancreatitis. The world’s top pancreatic experts believe a well-funded, coordinated research and development program could lead to effective treatments.
Mission: Cure is working to make that happen. Consulting with pancreatic experts from the world’s top research and healthcare institutions, we developed a plan and are working to implement it.
Our Approach
Financing Based on Patient Outcomes
Promising and Cost-Effective Methods to Cure Diseases
Active Collaboration Among Stakeholders
Partnerships with Impact Investors
We cannot do this without your support.
The time is right to create a new model for curing disease. Exciting developments in genetics and data are making precision medicine a reality.
Healthcare payers are moving toward value-based funding, especially for chronic diseases. And a new generation of impact investors — seeking to generate social and not just financial returns — have made curing disease a priority.
Latest News
Julie’s Pancreatitis Journey: From Diagnosis to Life Without a Pancreas
When I was 25, I was diagnosed with my first bout of acute pancreatitis which started a long journey with multiple ups and downs. I
Pancreatitis-Friendly Halloween Treats
Halloween can be a challenging time for those managing pancreatitis, but with some careful planning, you can still enjoy the festive spirit without compromising your
Type 3c Diabetes Q&A
Dr. Melena Bellin, MD is a leading endocrinologist with over 20 years of experience. She presented on Mission: Cure’s Pancreatitis Patient Webinar, ‘Understanding Type 3c